HealthEquity, Inc.

HealthEquity, Inc. (HQY) Market Cap

HealthEquity, Inc. has a market capitalization of $7.41B.

Price: $88.67

2.64 (3.07%)

Market Cap: 7.41B

NASDAQ · time unavailable

CEO: Scott R. Cutler

Sector: Healthcare

Industry: Medical - Healthcare Information Services

IPO Date: 2014-07-31

Website: https://www.healthequity.com

HealthEquity, Inc. (HQY) - Company Information

Market Cap: 7.41B|Sector: Healthcare

Company Profile

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. The company was incorporated in 2002 and is headquartered in Draper, Utah.

Analyst Sentiment

84%
Strong Buy

From 16 Active Polls

1Y Forecast: $107.33

▲ +21.0% Potential Upside

Consensus Target Metrics

Low Bound

$89

Median

$108

High Bound

$125

Average

$107

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$107.33
▲ +21.04% Upside
Low Target
$89.00
0% Risk
Median Target
$108.00
22% Mid
High Target
$125.00
41% Max
Consensus
Buy
25 / 27 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Period EndingTrailing 12MApr 30, 2026Jan 31, 2026Oct 31, 2025Jul 31, 2025Apr 30, 2025Jan 31, 2025Oct 31, 2024Jul 31, 2024
Market Cap ($M)7,4136,9247,3798,1338,3957,4289,5737,4336,838
Enterprise Value ($M)8,1327,6448,0618,8529,1468,24710,3868,2467,669
Price to Earnings Ratio (P/E)32.4424.9437.0939.3435.0734.4490.77325.8547.72
Price/Earnings-to-Growth Ratio (PEG)4.169.625.6423.951939.1011.13
Price to Sales Ratio (P/S)5.5419.5322.0525.2525.7722.4530.7024.7422.80
Price to Book Ratio (P/B)3.663.383.503.813.913.504.533.503.17
Price to Free Cash Flow Ratio (P/FCF)15.2071.2772.6859.0355.54152.86153.9395.68-67.73
Enterprise Value to Sales (EV/Sales)21.5524.0927.4828.0724.9333.3127.4525.57
Enterprise Value to EBITDA (EV/EBITDA)26.7672.14-149.5273.5569.5766.21123.05126.6872.58
Debt to Equity Ratio2.370.480.480.480.490.520.520.530.54

HQY Growth Runway Model

Standard long term linear growth fade

Multi-Stage Discounted Cash Flow Sandbox

Market Price$88.67
Intrinsic Value$112.32
Market Alignment
Undervalued by 26.7%relative to calculated intrinsic value
9.00%
Exp: 7%7%
i

Growth runway slowdown

This value provides a time window for the growth rate to decline beyond Stage 1 toward the terminal rate. Longer windows are most useful for companies with high growth starting conditions or strong competitive advantages. This option stretches out the growth rate slowdown across 5, 10, or 15-year steps. A high-growth starting condition (exceeding a 25% initial growth rate) automatically applies a curve decay to simulate realistic, rapid market saturation.
i

Terminal growth rate

With long-term inflation between 3-5%, revenue must grow by that baseline to maintain flat real-world market share. This value sets the permanent terminal growth rate to factor into the valuation beyond the growth slowdown runway toward maturity.

3-Stage Financial Runway Horizon

🧠 Perpetuity Horizon Engine (Stage 3: Post-2036)

Terminal FCF Base$0.78B
Perpetuity TV Value$14.75B
Discounted TV (PV)$5.72B
TV Weighting %59.4%
⚠️
Financial Model Disclaimer & Risk Disclosure: This interactive scenario simulator is an educational sandbox provided strictly for informational and analytical research purposes. Core historical financial statements and consensus estimates are sourced directly via Financial Modeling Prep (FMP). All downstream outputs are entirely deterministic, hypothetical projections generated by combining automated mathematical formulas (including linear interpolation and Gaussian bell-curve decay models) with user-selected variables and third-party financial data inputs. Users assume all liability for trading decisions executed based on these sandbox calculations.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 HEALTHEQUITY INC (HQY) — Investment Overview

🧩 Business Model Overview

HEALTHEQUITY INC administers health savings accounts (HSAs) and related consumer-directed healthcare benefits for employers, plan administrators, and financial institution partners. The value chain centers on (1) enrolling individuals into tax-advantaged accounts, (2) managing account servicing and compliance, and (3) enabling benefit spending through integrated debit/processing services and digital tools.

Revenue is driven by the growth and ongoing servicing of account balances and transactions—creating customer stickiness as account holders and employers rely on an established platform for funding, rules-based eligibility, contributions, and payment execution.

💰 Revenue Streams & Monetisation Model

HQY’s monetisation model combines recurring account administration economics with transaction and servicing fees:

  • Recurring account servicing and administration fees: Contracted or per-account economics tied to maintaining HSA relationships.
  • Payment and spend-related fees: Revenue tied to debit/processing and card usage and associated service features.
  • Investment/“float”-like economics: Benefits from HSA cash flows and balances that can be invested, subject to applicable regulatory and risk management constraints.

Margin drivers typically include (1) growth in net funded balances and contribution volume, (2) operating leverage from servicing scale, (3) fee take rates on account and payment activity, and (4) economics of invested balances (net of funding costs, credit exposure, and regulatory constraints).

🧠 Competitive Advantages & Market Positioning

HQY’s moat is best characterized as a combination of high switching costs (data and operational integration) and regulatory/service barriers (complexity of HSA administration and compliance), reinforced by an integrated ecosystem across account servicing and spending.

  • Switching costs / data gravity: Employers and account holders benefit from established workflows (contributions, eligibility handling, reporting, and spend experiences). Moving accounts can be operationally burdensome due to compliance timelines, data migration, and process reconfiguration.
  • High-barriers service capability: Accurate, compliant administration at scale is difficult to replicate without deep systems, controls, and operational expertise.
  • Integrated ecosystem: Bundling account administration with payment enablement supports cross-sell of services and improves retention.

COMPETITIVE BENCHMARKING: Primary competitors include Optum Bank (UnitedHealth), Fidelity, and U.S. Bank / PayFlex (among other benefits administrators and banking partners).

Industry focus contrast: While large financial institutions and insurers often distribute HSAs as part of broader financial or healthcare offerings, HQY’s positioning emphasizes dedicated consumer-directed healthcare administration plus payment enablement—supporting a more product-specialized platform. This specialization can matter where employers and partners want a high-throughput, technology-led administration and spend experience with consistent compliance tooling.

🚀 Multi-Year Growth Drivers

Over a 5–10 year horizon, the opportunity set is supported by structural adoption of consumer-directed healthcare:

  • HDHP penetration and HSA adoption: As employers and individuals shift toward high-deductible plan designs, HSAs become a primary savings and spending vehicle.
  • Tax-advantaged compounding incentives: The HSA’s favorable tax treatment creates durable demand for account longevity and ongoing contributions.
  • Transaction and digital spend expansion: Increased card usage, digital onboarding, and payroll contribution workflows can lift monetisation per participant over time.
  • Partner channel development: Growth via employer relationships and financial institution partners supports account inflows without solely relying on direct-to-consumer acquisition.

The long-term growth thesis rests on building a larger installed base and deepening economics per account through servicing, spend enablement, and value-added tools—while leveraging operating scale.

⚠ Risk Factors to Monitor

  • Regulatory risk to HSA rules: Changes to contribution limits, eligibility, qualified expense definitions, or administrative requirements can alter customer behavior and account economics.
  • Investment/balance economics volatility: The economics tied to invested HSA balances can be sensitive to interest rate conditions, market spreads, liquidity requirements, and risk constraints.
  • Competitive pricing and partner deal pressure: Large incumbents may compete aggressively on fees, bundled benefits administration, or banking services, pressuring take rates.
  • Operational and security risk: As a custodian-like administrator for sensitive financial and health-related data, cyber risk and operational failures can damage trust and retention.
  • Credit and fraud controls: Payment and spend-related fraud management and underwriting controls must remain robust to protect unit economics.

📊 Valuation & Market View

Market participants typically value this category using a blend of revenue quality metrics (recurring fee base), installed base growth (account and balance growth), and cash generation sensitivity (including investment spread/float-like economics, where applicable).

Key valuation drivers commonly include:

  • Account growth and net funded balances: Sustained inflows improve servicing economics and investment-related earnings power.
  • Fee mix and operating leverage: Higher contribution and spend activity can support margin progression.
  • Retention and churn: Durable relationships reduce unit volatility.
  • Regulatory and balance-economics outlook: Expectations for HSA administrative and investment rules affect risk-adjusted returns.

🔍 Investment Takeaway

HEALTHEQUITY INC presents an institutional long-term thesis anchored in a specialized consumer-directed healthcare administration platform, where switching costs, compliance-driven barriers, and integrated account-and-spend capabilities support durability of the customer base. Multi-year growth is tied to structural expansion in HDHP and HSA adoption, with upside from deeper monetisation via transaction enablement and operating scale. The primary underwriting focus should remain on regulatory durability and the stability of balance-investment economics.


⚠ AI-generated — informational only. Validate using filings before investing.

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for HQY.

zacks.com2026-06-04

3 Reasons Why Growth Investors Shouldn't Overlook HealthEquity (HQY)

HealthEquity (HQY) possesses solid growth attributes, which could help it handily outperform the market.

zacks.com2026-06-04

Wall Street Analysts See a 33.49% Upside in HealthEquity (HQY): Can the Stock Really Move This High?

The consensus price target hints at a 33.5% upside potential for HealthEquity (HQY). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

zacks.com2026-06-04

Why HealthEquity (HQY) is a Top Momentum Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

zacks.com2026-06-03

Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

zacks.com2026-05-29

HealthEquity Stock Gains as Q1 Earnings Top Estimates, Revenues Up Y/Y

HQY tops Q1 FY27 EPS and revenue estimates as HSA accounts and assets climb, and guidance for FY27 revenues and adjusted EPS rises.

seekingalpha.com2026-05-29

HealthEquity, Inc. (HQY) Q1 2027 Earnings Call Transcript

HealthEquity, Inc. (HQY) Q1 2027 Earnings Call Transcript

zacks.com2026-05-28

HealthEquity (HQY) Reports Q1 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for HealthEquity (HQY) give a sense of how the business performed in the quarter ended April 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

gurufocus.com2026-05-28

A Look at HealthEquity Inc (HQY) After 4.6% Gain -- GF Value $101.45 vs Price $90.52

On May 28, 2026, HealthEquity Inc (HQY) shares rose by 4.6%, bringing the current price to $90.52. Over the past year, the stock has seen a 52-week range from a

zacks.com2026-05-28

HealthEquity (HQY) Q1 Earnings and Revenues Top Estimates

HealthEquity (HQY) came out with quarterly earnings of $1.24 per share, beating the Zacks Consensus Estimate of $1.11 per share. This compares to earnings of $0.97 per share a year ago.

marketbeat.com2026-05-28

HealthEquity Q1 Earnings Call Highlights

HealthEquity NASDAQ: HQY raised its fiscal 2027 outlook after reporting higher first-quarter profitability, record revenue in key categories and expanded margins, with management pointing to account growth, deeper member engagement and operating efficiencies from technology and artificial intelligence.

globenewswire.com2026-05-28

HealthEquity Reports First Quarter Ended April 30, 2026 Financial Results; Raises Guidance

Increases Repurchase Program by $1.0 Billion Highlights of the first quarter include: Net income increased 29% to $69.4 million, and net income margin increased to 20% from 16% last year. Adjusted EBITDA increased 17% to $164.5 million, and Adjusted EBITDA margin increased to 46% from 42% last year.

247wallst.com2026-05-22

The Triple Tax Free HSA Account High Earners Are Funding Before Maxing Their 401(k)

Picture a dual-income couple with combined wages well into the high six figures. They already max the 401(k). Their employer offers a high-deductible health plan, and they keep choosing the lower-premium PPO out of habit. That habit is costing them the most tax-advantaged account in the entire IRS code. The HSA is the only vehicle... The Triple Tax Free HSA Account High Earners Are Funding Before Maxing Their 401(k)

seekingalpha.com2026-05-22

HealthEquity: Compounding Flywheel Reveals Attractive Entry Point

HealthEquity is a leading HSA administrator, benefiting from rising healthcare costs and recent legislative tailwinds expanding its addressable market. Revenue grew 9% in FY2026 to $1.313 billion, with significant margin expansion and a standout 17% growth in custodial revenue driven by enhanced rate migration. Management projects further yield increases in FY2027, and a major low-yield contract expiry is set to boost custodial revenue meaningfully.

zacks.com2026-05-22

What Makes HealthEquity (HQY) a New Buy Stock

HealthEquity (HQY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

zacks.com2026-05-22

Wall Street's Insights Into Key Metrics Ahead of HealthEquity (HQY) Q1 Earnings

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for HealthEquity (HQY), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended April 2026.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-04-30

"HQY reported Q1’27 Revenue of $354.6M (+7.2% QoQ from $334.6M; +7.2% YoY from $330.8M). Net Income was $69.4M (+39.5% QoQ from $49.7M; +28.7% YoY from $53.9M) and EPS rose to $0.82. Profitability strengthened across the quarter: net margin improved to 19.6% from 14.9% in Q4, and gross margin expanded to 72.3% versus 92.4% in Q4 (noting Q4’s unusually high gross margin), while operating margin improved to 29.0% from 20.1%. Cash flow remained strong but volatile: operating cash flow was $97.5M (QoQ below Q4’s $117.9M, but above Q1’26’s $64.7M). Free cash flow was $97.2M, and the company continued heavy capital return via buybacks (-$123.3M in the quarter). Balance sheet resilience appears solid for a non-bank: cash and cash equivalents were $265.4M and net debt was negative (-$223.3M), indicating net cash. Equity was stable at ~$2.05B. On total shareholder returns, the stock price was $86.04 with only +4.3% over the last year (below a 20% momentum threshold). Dividend paid was $0, so returns are primarily from buybacks/valuation. Analyst valuation context: consensus price target is $109.89 vs. $86.04 current (~+27.7% upside)."

Revenue Growth

Positive

Revenue grew +7.2% QoQ (to $354.6M) and +7.2% YoY (vs. $330.8M), indicating steady top-line momentum.

Profitability

Good

Net income rose +39.5% QoQ and +28.7% YoY. Net margin expanded to 19.6% (from 14.9% in Q4). Operating margin improved to 29.0% (from 20.1% in Q4).

Cash Flow Quality

Positive

Operating cash flow was $97.5M and free cash flow $97.2M. Continued large buybacks (-$123.3M) with no dividends, supporting shareholder returns but increasing cash outflow variability.

Leverage & Balance Sheet

Good

Net debt is negative (-$223.3M) and liquidity is strong (cash $265.4M). Total equity is stable around ~$2.05B, suggesting balance-sheet resilience.

Shareholder Returns

Neutral

No dividend; buybacks are the key return mechanism. Price momentum was modest: +4.3% 1Y, below the >20% momentum threshold.

Analyst Sentiment & Valuation

Positive

Consensus target $109.89 vs. $86.04 current implies ~+27.7% upside, signaling constructive sentiment.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

HealthEquity delivered strong Q1 profitability with clear bps-driven margin expansion (gross margin +400 bps to 72%, adjusted EBITDA margin +400 bps to 46%) alongside disciplined capital allocation (accelerated $123m repurchase and +$1b authorization). Growth was powered by the compounding HSA flywheel: HSA assets +19% and new HSAs +15% (172k), plus engagement acceleration via Mark and digital usage (mobile MAUs +90%, >2/3 marketplace transactions on mobile). Management’s AI narrative was financially tangible: fraud reimbursements dropped from ~$3.2m to ~$0.3m and AI automation reduced manual handling of key workflows by >90%, cutting card contacts by >50k and improving fraud metrics below target. Fiscal 27 guidance was raised with revenue $1.41b–$1.42b and adjusted EBITDA $625m–$633m, plus an average HSA cash yield of ~3.85% backed by forward rate locks. Key diligence point: service cost beat appears utilization-driven and expected to partially reverse.

AI IconGrowth Catalysts

  • Total HSA assets +19% YoY; new HSAs +15% YoY (172k new HSAs) and total HSA growth +8%, outperforming Devenir’s reported 6% market growth for CY2025
  • Engagement flywheel via Mark: >10k+ members accessing health programs; expanded Mark into diagnostics and men’s health to drive marketplace conversion
  • Investing momentum: HSA investors +18% YoY; invested assets held by members +38% YoY, supported by low industry penetration (~10% using full investing tax benefits)
  • Digital activation: mobile monthly active usage +90% YoY; >2/3 of marketplace transactions via mobile app

Business Development

  • Depository partner exited a custodial cash contract early, contributing a one-time breakage fee (impacting HSA cash yield) and indicating ongoing contract re-optimizations
  • Marketplace program expansion: added TRT and diagnostics and men’s health; no explicit new external partner names provided in the excerpt

AI IconFinancial Highlights

  • Revenue +7% YoY; Service revenue record $123m (+3% YoY) supported by marketplace activity; Custodial revenue record $174m (+11% YoY)
  • Adjusted EBITDA margin expanded to 46% vs 42% prior-year quarter (+400 bps) with Adjusted EBITDA $165m (+17% YoY)
  • Gross profit margin improved to 72% vs 68% (+400 bps) YoY
  • GAAP EPS $0.82; non-GAAP EPS $1.24 (diluted) vs internal expectations not stated in transcript
  • Annualized yield on HSA cash 3.84%; excluding one-time breakage fee yield would have been 3.78% (one-time uplift)
  • Service costs: fraud reimbursements ~ $0.3m vs ~$3.2m YoY prior period; fraud cost declined nearly 90% YoY; service efficiency improvements supported by AI automation
  • Q1 fraud reimbursements and contact reductions attributed to improved fraud prevention/detection and secure mobile tools; AI reduced manual handling of service emails by 25% and claims/card workflows by >90% manual effort with processing accelerated up to 50%

AI IconCapital Funding

  • Share repurchase: accelerated repurchase of $123m during the quarter; board increased share repurchase authorization by $1.0b
  • Balance sheet: cash $265m at quarter end; operating cash flow $98m during the quarter
  • Debt outstanding: ~$943m net of issuance costs
  • Guidance commentary: potential revolver reductions during fiscal 27; expectation to remain an active share buyer while preserving revolver availability for portfolio acquisitions

AI IconStrategy & Ops

  • AI as an “operational amplifier”: reduced manual handling of member/client service emails by 25%; targeted workflows (card servicing and claims inquiries) reduced manual efforts by >90%; accelerated processing by up to 50%
  • Reduced card-related service center contacts by >50k via AI-enabled self-service/automation
  • Fraud metrics: fraud remained below target; card acceptance improved; fraud cost declined nearly 90% YoY
  • Digital product strategy: single AI/personalized app as the long-term conduit for self-service, education, and marketplace engagement (app features cited: push-button card activation)
  • Self-service and automation expansion emphasized as the primary driver of service cost per account improvements

AI IconMarket Outlook

  • Fiscal 27 raised guidance (as provided): Revenue $1.41b–$1.42b; GAAP net income $242m–$248m ($2.88–$2.95 per share); Non-GAAP net income $292m–$398m ($4.66–$4.73 per share) (shares assumed 84m for the year
  • Adjusted EBITDA guidance $625m–$633m
  • Average yield on HSA cash expected ~3.85% during fiscal 27 (with rate-lock/forward treasury contracts cited to reduce volatility)

AI IconRisks & Headwinds

  • Healthcare utilization and medical claims variability: management noted internal utilization beats expectations due to lower medical claim usage; guided assumption may mean cost will “come back” and therefore beat was pushed into the forecast rather than banking on continued favorable utilization
  • AI cost risk: AI compute/token usage can increase tech/dev costs; management expects to keep spend within an overall tech/dev envelope while still driving operating efficiency
  • Market growth concentration: HSA category growth described as “winner-take-most” with top players capturing disproportionate growth; competitive pressure implied for ongoing market-share capture
  • Marketplace economics not yet broken out; reliance on continued engagement-to-transaction conversion for marketplace growth durability

Q&A: Analyst Interest

  • Mark marketplace gating and go-to-market design: Management said there’s no marketing-spend gating; growth starts with member engagement. Q1 focused on scaling foundations (visibility, MarkTech capabilities, new programs TRT and diagnostics). Conversion depends on driving mobile monthly active users and then exposing members to marketplace.
  • AI’s expense-to-savings mechanics: Analysts asked whether AI investment should reduce tech/development costs, given cap/software growth. Management acknowledged token/compute costs could rise but emphasized they’re kept within a revenue-linked tech/dev spend envelope. Major savings came via reduced manual resolution time (up to 90%) and automation in targeted service journeys.
  • Service cost bridge and utilization assumptions: Management addressed YoY service cost improvement and whether it was one-time. They cited medical claim usage below expectations, pushing the beat into the forecast. They expect costs to normalize, describing it as seasonal/marketwide with no change to payer/corporate clients’ medical utilization assumptions.

Sentiment: POSITIVE

Note: This summary was synthesized by AI from the HQY Q1 2027 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

📋 Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for HQY.

SEC EDGAR Live Feed
Loading financial data and tables...
📁

SEC Filings (HQY)

© 2026 Stock Market Info — HealthEquity, Inc. (HQY) Financial Profile